Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets (Parenthetical)

v3.20.1
Consolidated Balance Sheets (Parenthetical) - USD ($)
$ in Thousands
Dec. 31, 2019
Dec. 31, 2018
Restricted cash $ 49,637 $ 53,726
Notes receivable, net $ 449,162 $ 439,167
Common Stock, par value $ 0.01 $ 0.01
Common stock, shares authorized 100,000,000 100,000,000
Common stock, shares issued 74,362,693 74,445,923
Common stock, shares outstanding 74,362,693 74,445,923
Variable Interest Entity, Primary Beneficiary [Member]    
Restricted cash $ 22,534 $ 28,400
Notes receivable, net $ 292,590 $ 341,975